Hypogammaglobulinemia, X-Linked: Clinical Trials

1 trial for Hypogammaglobulinemia, X-Linked, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Hypogammaglobulinemia, X-Linked: new trials by email Literature Review of Hypogammaglobulinemia, X-Linked trials Research Report on Hypogammaglobulinemia, X-Linked

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.
Gammaplex (Intravenous immunoglobulin) - Primary Immunodeficiency, Common Variable Hypogammaglobulinemia
Phase 3CompletedBio Products Laboratory502006-01-012013-01-24

Narrower conditions

Agammaglobulinemia (1)  ·  Common Variable Immunodeficiency (1)  ·  Hyper-IgM Immunodeficiency Syndrome (1)  ·  Primary Immunodeficiency Diseases (1)  ·  Wiskott-Aldrich Syndrome (1)

Broader conditions

Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)  ·  Blood Protein Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Cytopenia (1)  ·  Dysgammaglobulinemia (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Leukocyte Disorders (1)  ·  Leukopenia (1)

Interventions

Immunoglobulins, Intravenous (1)  ·  gamma-Globulins (1)

Sponsors

Bio Products Laboratory (1)

Countries

United States (1)

Top investigators

Melvin Berger, MD (1)

Results publications

PMID 36818468